Show simple item record

dc.contributor.authorSontheimer, Erik J.
dc.contributor.authorDavidson, Alan R.
dc.date2022-08-11T08:10:52.000
dc.date.accessioned2022-08-23T17:22:50Z
dc.date.available2022-08-23T17:22:50Z
dc.date.issued2017-06-01
dc.date.submitted2018-07-20
dc.identifier.citation<p>Curr Opin Microbiol. 2017 Jun;37:120-127. doi: 10.1016/j.mib.2017.06.003. Epub 2017 Jun 29. <a href="https://doi.org/10.1016/j.mib.2017.06.003">Link to article on publisher's site</a></p>
dc.identifier.issn1369-5274 (Linking)
dc.identifier.doi10.1016/j.mib.2017.06.003
dc.identifier.pmid28668720
dc.identifier.urihttp://hdl.handle.net/20.500.14038/48829
dc.description.abstractClustered, regularly interspaced, short, palindromic repeats (CRISPR) loci, together with their CRISPR-associated (Cas) proteins, provide bacteria and archaea with adaptive immunity against invasion by bacteriophages, plasmids, and other mobile genetic elements. These host defenses impart selective pressure on phages and mobile elements to evolve countermeasures against CRISPR immunity. As a consequence of this pressure, phages and mobile elements have evolved 'anti-CRISPR' proteins that function as direct inhibitors of diverse CRISPR-Cas effector complexes. Some of these CRISPR-Cas complexes can be deployed as genome engineering platforms, and anti-CRISPRs could therefore be useful in exerting spatial, temporal, or conditional control over genome editing and related applications. Here we describe the discovery of anti-CRISPRs, the range of CRISPR-Cas systems that they inhibit, their mechanisms of action, and their potential utility in biotechnology.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28668720&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737815/
dc.subjectBiochemistry, Biophysics, and Structural Biology
dc.subjectGenetics and Genomics
dc.subjectImmunity
dc.subjectMicrobiology
dc.subjectTherapeutics
dc.titleInhibition of CRISPR-Cas systems by mobile genetic elements
dc.typeJournal Article
dc.source.journaltitleCurrent opinion in microbiology
dc.source.volume37
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/rti_pubs/39
dc.identifier.contextkey12515847
html.description.abstract<p>Clustered, regularly interspaced, short, palindromic repeats (CRISPR) loci, together with their CRISPR-associated (Cas) proteins, provide bacteria and archaea with adaptive immunity against invasion by bacteriophages, plasmids, and other mobile genetic elements. These host defenses impart selective pressure on phages and mobile elements to evolve countermeasures against CRISPR immunity. As a consequence of this pressure, phages and mobile elements have evolved 'anti-CRISPR' proteins that function as direct inhibitors of diverse CRISPR-Cas effector complexes. Some of these CRISPR-Cas complexes can be deployed as genome engineering platforms, and anti-CRISPRs could therefore be useful in exerting spatial, temporal, or conditional control over genome editing and related applications. Here we describe the discovery of anti-CRISPRs, the range of CRISPR-Cas systems that they inhibit, their mechanisms of action, and their potential utility in biotechnology.</p>
dc.identifier.submissionpathrti_pubs/39
dc.contributor.departmentRNA Therapeutics Institute
dc.source.pages120-127


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record